http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3389132

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 28
issn 1948-5875
issueIdentifier 1
pageRange 27-28
publicationName ACS Medicinal Chemistry Letters
startingPage 27
bibliographicCitation Sabnis RW. Novel Macrocyclic Peptidylarginine Deiminase Type 4 (PAD4) Inhibitors. ACS Med. Chem. Lett. 2022 Jan 03;13(1):27–8. doi: 10.1021/acsmedchemlett.1c00689.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7289-0581
date 2022-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1021/acsmedchemlett.1c00689
https://pubmed.ncbi.nlm.nih.gov/35059120
https://pubmed.ncbi.nlm.nih.gov/PMC8762737
isPartOf https://portal.issn.org/resource/ISSN/1948-5875
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37641
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Novel Macrocyclic Peptidylarginine Deiminase Type 4 (PAD4) Inhibitors

Incoming Links

Predicate Subject
citesAsDataSource http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID475988155_AID1813806_PMID35059120_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID475978920_AID1813806_PMID35059120_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID476000162_AID1813806_PMID35059120_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID475977733_AID1813806_PMID35059120_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID475996376_AID1813806_PMID35059120_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID475987898_AID1813806_PMID35059120_VALUE3
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23569

Total number of triples: 26.